Pharmafile Logo
Pharmafocus logo
Advanced Search
Pfizer's hacked Facebook page

Digital Pharma: Pfizer’s Facebook page hacked

July 22, 2011
Medical Communications Digital Pharma blog, Facebook, Pfizer

Pfizer has regained control of its corporate Facebook page after hackers temporarily defaced it earlier this week. A UK group …

News

Lilly posts strong quarterly results, faces challenges ahead

July 22, 2011
Sales and Marketing lilly, patent expiry

Lilly edged toward double-digit growth in the second quarter, but looming patent expires threaten this trend. Second quarter revenue grew …

News

Teva closes one Canadian plant, expands two more

July 22, 2011
Manufacturing and Production Canada, Teva

Teva Pharmaceutical has decided to shut down its recently-acquired manufacturing Canadian facility in Montreal, Quebec, having failed to find a …

News

Merck and Roche extend Victrelis co-promotion deal to Europe

July 22, 2011
Sales and Marketing Merck & Co, Roche, Victrelis, hepatitis C

Merck & Co is ramping up efforts to push its new hepatitis C treatment Victrelis to the fore, signing a …

News

European reprieve for Takeda’s Actos

July 22, 2011
Sales and Marketing Actos, diabetes

Takeda’s Actos is likely to remain on the market in Europe but regulators want the diabetes drug to carry stronger …

News
Blog footer

Digital Pharma: Mobile app regulation

July 21, 2011
Medical Communications, Sales and Marketing Digital Phama blog, app, ipad, iphone, mobile

The FDA has proposed new rules for smartphone apps, but says the guidelines will only apply to a small number …

News

Service Insight: Logical logistics

July 21, 2011
Manufacturing and Production Service Insight, manufacturing and production

SERVICE INSIGHTThere is no mistaking that we have been faced with turbulent times over the last year or so and …

Feature
AZ's Brilinta (ticagrelor)

FDA approves AstraZeneca’s Brilinta after delay

July 21, 2011
Sales and Marketing AstraZeneca, Brilinta, Brilique, antiplatelet

The FDA has finally approved AstraZeneca’s oral blood thinner Brilinta after asking for more information on the drug last year.  …

News

MSI appoints new managing director

July 21, 2011
Sales and Marketing appointment, sales and marketing

UK-based pharmaceutical consultancy the MSI Consultancy has appointed Jon Bircher as managing director. He joined MSI in January 2006 from …

Appointment
Eli Lilly & Co

Lilly presents data on failed Alzheimer’s candidate

July 21, 2011
Research and Development Alzheimer's disease, lilly, research and development news, semagacestat

Lilly has presented a review of data from semagacestat, the Alzheimer’s drug it dropped last year after disappointing results. Phase …

News

AZ adds new heart warning to Seroquel

July 21, 2011
Sales and Marketing Seroquel, antipsychotic

AstraZeneca has added a new heart warning to the packaging on its antipsychotic drug Seroquel at the behest of the …

News

Merck signs major deal with China’s Simcere

July 21, 2011
Sales and Marketing Merck, Simcere, emerging markets

Merck is to establish a joint venture with China’s Simcere focused on serving China’s rapidly expanding health care needs by …

News

Moorfields Pharmaceuticals and MC2 Biotek Group enter into a collaboration and licence agreement to develop new ophthalmic products

July 20, 2011
Manufacturing and Production

Moorfields Pharmaceuticals and MC2 Biotek have signed a collaboration and licence agreement concerning development of novel ophthalmic products addressing unmet …

News
Press release

NICE says no to breast cancer treatment Halaven

July 20, 2011
Sales and Marketing Eisai, Halaven, NICE

Eisai’s Halaven has been rejected by NICE in draft guidance for locally advanced or metastatic breast cancer. Halaven (eribulin) is …

News

Analysis paralysis – how to get the true measure of clinical trials

July 20, 2011
Research and Development Les Rose, clinical trials

The great physicist Lord Kelvin famously said: “When you can measure what you are speaking about, and express it in …

Feature

Future of AZ-BMS diabetes drug in doubt

July 20, 2011
Research and Development, Sales and Marketing AstraZeneca, BMS, dapagliflozin, diabetes, research and development news

A US advisory committee has rejected an investigational compound for type II diabetes sufferers, throwing its future into doubt. Dapagliflozin, …

News
MSD's Victrelis (boceprevir)

Hep C drug Victrelis gains EU approval

July 20, 2011
Sales and Marketing Incivek, Victrelis, hepatitis C

Merck Sharp & Dohme’s Victrelis, one of two major new hepatitis C drugs, has gained final approval in Europe. Victrelis …

News

Contract research news in brief

July 20, 2011
Research and Development research and development news

M&A abounds in the CRO sector with INC completing its purchase of Kendle, inVentiv snappig up Pharmanet and ICON buying …

News

Government seeks to salvage pharma pricing reforms

July 19, 2011
Sales and Marketing NICE, value-based pricing

The government is pushing ahead with plans to introduce value-based pricing in 2014, despite acknowledging the new system still requires …

News
Victrelis

Hepatitis C rivals go head to head

July 19, 2011
Sales and Marketing Incivek, Incivo, Victrelis, boceprevir, hepatitis C, telaprevir

 The field of hepatitis C treatment has two new groundbreaking medicines to treat the condition.Merck’s Victrelis (boceprevir) and Johnson & …

Feature
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026